Seeking Alpha

Healthcare upgrades for Monday

  • McKesson (MCK -0.1%) upgraded to Strong Buy from Outperform at Raymond James.
  • DaVita (DVA +0.4%) upgraded to Outperform from Market Perform at Raymond James.
  • Idenix Pharmaceuticals (IDIX -0.3%) upgraded to Buy from Neutral at UBS.
  • Abbott Labs (ABT +1.5%) upgraded to Overweight from Equalweight at Morgan Stanley.
  • Medtronic (MDT +2%upgraded to Overweight from Neutral at JPMorgan. Price target is $69.
  • Vertex Pharmaceuticals (VRTX +2.5%) upgraded to Buy from Neutral at UBS.
  • Ocera Therapeutics (OCRX +2.7%) upgraded to Outperform from Market Perform at BMO.
  • Boston Scientific (BSX +3.2%upgraded to Overweight from Equalweight at Morgan Stanley.
  • Exelixis (EXEL +4.6%) upgraded to Overweight from Neutral at Piper.
  • St. Jude Medical (STJ +3.8%) upgraded to Overweight from Equalweight at Morgan Stanley.
Comments (3)
  • BlueOkie
    , contributor
    Comments (4484) | Send Message
     
    The healthcare sector seems to be on the rise! Guess Uncle Sam is going to spend a lot of money in that area in coming days, months and years.
    6 Jan, 02:13 PM Reply Like
  • ralph111
    , contributor
    Comments (128) | Send Message
     
    we are uncle sam
    6 Jan, 04:58 PM Reply Like
  • gofergold
    , contributor
    Comments (5) | Send Message
     
    Our tax dollars at work
    6 Jan, 06:28 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|